| scholarly article | Q13442814 |
| P2093 | author name string | N Ghahramani | |
| A Parhizgar | |||
| A Mirhosseini | |||
| G Hychko | |||
| P2860 | cites work | Future strategies toward the cure of indolent B-cell malignancies. New biologic therapies | Q33755682 |
| IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma | Q34440364 | ||
| Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment | Q34977911 | ||
| Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection | Q36017741 | ||
| Current approaches to treatment of antibody-mediated rejection | Q36135427 | ||
| Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival | Q37315152 | ||
| CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma. | Q37581348 | ||
| Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis | Q37768109 | ||
| Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature | Q37813942 | ||
| IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma | Q40645948 | ||
| Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines | Q41236932 | ||
| Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab | Q42788268 | ||
| Treatment of Acute Antibody-Mediated Rejection: A Single-Center Experience | Q42849688 | ||
| Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study | Q42872376 | ||
| High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone | Q43109656 | ||
| Protein A immunoadsorption combined with rituximab in highly sensitized kidney transplant recipients. | Q43232856 | ||
| Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient | Q43605225 | ||
| A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection | Q44197767 | ||
| Rituximab as treatment for refractory kidney transplant rejection | Q44899030 | ||
| Impact of rituximab therapy for treatment of acute humoral rejection | Q45361905 | ||
| Rituximab in highly sensitized kidney transplant recipients | Q46369189 | ||
| Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma | Q46898582 | ||
| Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection | Q46913121 | ||
| Banff 2003 meeting report: new diagnostic insights and standards. | Q53285195 | ||
| Rituximab: an insider's historical perspective. | Q53495249 | ||
| Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. | Q54013696 | ||
| Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. | Q54561806 | ||
| Interstitial pneumonitis related to rituximab therapy. | Q55036634 | ||
| Late onset Pneumocystis pneumonia in patients receiving rituximab for humoral renal transplant rejection | Q60651384 | ||
| Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts | Q73338525 | ||
| Impact of humoral alloreactivity on the survival of renal allografts | Q77176038 | ||
| C4d deposition in acute rejection: an independent long-term prognostic factor | Q77374161 | ||
| Rituximab therapy for acute humoral rejection after kidney transplantation | Q80318231 | ||
| A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation | Q82026577 | ||
| Rituximab-induced fatal interstitial pneumonitis: case report | Q82352651 | ||
| Acute humoral rejection in an ABO compatible combined liver-kidney transplant--the kidney is not always protected | Q84065061 | ||
| Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy | Q85154448 | ||
| P433 | issue | 2 | |
| P921 | main subject | rituximab | Q412323 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 51-56 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | International journal of organ transplantation medicine | Q26853977 |
| P1476 | title | A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection | |
| P478 | volume | 2 |
Search more.